TY - JOUR
T1 - Emerging trends and new developments in monoclonal antibodies
T2 - A scientometric analysis (1980–2016)
AU - Lai, Yunfeng
AU - Wang, Ruibing
AU - Chen, Xin
AU - Tang, Daisheng
AU - Hu, Yuanjia
AU - Cai, Jing
AU - Zhang, Qingwen
AU - Hu, Hao
N1 - Publisher Copyright:
© 2017 Taylor & Francis.
PY - 2017/6/3
Y1 - 2017/6/3
N2 - This article aims to explore the intellectual landscape of the study of monoclonal antibody (mAb), mainly to identify thematic trends, landmark articles and emerging trends involving mAb. This work is based on 4 sets of bibliographic records retrieved from the Web of Science. The final data set, consisting of 7,385 bibliographic records, was combined from the 4 individual data sets. This study explores the document co-citation clusters of 7,385 bibliographic records to identify the origin of mAb and the hot research specialty of this domain by applying CiteSpace software. We examined the mAb evolution from 4 perspectives: (1) Clusters of cited references regarding mAb; (2) Cited authors as contributors to mAb research; (3) Institutions participating in mAb research; and (4) Cited journals regarding mAb. The technical development, drug development and clinical applications of mAbs were analyzed. Through data analysis, we have identified the new directions for the exploration of mAbs, interactions between mAb technologies and diseases, and evolving global collaboration among institutions.
AB - This article aims to explore the intellectual landscape of the study of monoclonal antibody (mAb), mainly to identify thematic trends, landmark articles and emerging trends involving mAb. This work is based on 4 sets of bibliographic records retrieved from the Web of Science. The final data set, consisting of 7,385 bibliographic records, was combined from the 4 individual data sets. This study explores the document co-citation clusters of 7,385 bibliographic records to identify the origin of mAb and the hot research specialty of this domain by applying CiteSpace software. We examined the mAb evolution from 4 perspectives: (1) Clusters of cited references regarding mAb; (2) Cited authors as contributors to mAb research; (3) Institutions participating in mAb research; and (4) Cited journals regarding mAb. The technical development, drug development and clinical applications of mAbs were analyzed. Through data analysis, we have identified the new directions for the exploration of mAbs, interactions between mAb technologies and diseases, and evolving global collaboration among institutions.
KW - CiteSpace
KW - intellectual landscape
KW - mAb
KW - monoclonal antibody
KW - scientometric
UR - http://www.scopus.com/inward/record.url?scp=85015612977&partnerID=8YFLogxK
U2 - 10.1080/21645515.2017.1286433
DO - 10.1080/21645515.2017.1286433
M3 - 文章
C2 - 28301271
AN - SCOPUS:85015612977
SN - 2164-5515
VL - 13
SP - 1388
EP - 1397
JO - Human Vaccines and Immunotherapeutics
JF - Human Vaccines and Immunotherapeutics
IS - 6
ER -